Global Novel Antiviral Drugs Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Novel Antiviral Drugs Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Novel Antiviral Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Reverse Transcriptase Inhibitors
  • 1.4.3 Protease Inhibitors
  • 1.4.4 Fusion Inhibitors
  • 1.4.5 Immune System Modulators
  • 1.4.6 Other
• 1.5 Market by Application
  • 1.5.1 Global Novel Antiviral Drugs Market Share by Application: 2020 VS 2026
  • 1.5.2 Hepatitis Therapeutics
  • 1.5.3 HIV/AIDS Therapeutics
  • 1.5.4 Herpes Therapeutics
  • 1.5.5 Influenza Therapeutics
  • 1.5.6 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Novel Antiviral Drugs Market Perspective (2015-2026)
• 2.2 Novel Antiviral Drugs Growth Trends by Regions
  • 2.2.1 Novel Antiviral Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Novel Antiviral Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Novel Antiviral Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Novel Antiviral Drugs Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Novel Antiviral Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Novel Antiviral Drugs Players by Market Size
  • 3.1.1 Global Top Novel Antiviral Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Novel Antiviral Drugs Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Novel Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Novel Antiviral Drugs Market Concentration Ratio
  • 3.2.1 Global Novel Antiviral Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Novel Antiviral Drugs Revenue in 2019
• 3.3 Novel Antiviral Drugs Key Players Head office and Area Served
• 3.4 Key Players Novel Antiviral Drugs Product Solution and Service
• 3.5 Date of Enter into Novel Antiviral Drugs Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Novel Antiviral Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Novel Antiviral Drugs Forecasted Market Size by Type (2021-2026)

5 Novel Antiviral Drugs Breakdown Data by Application (2015-2026)

• 5.1 Global Novel Antiviral Drugs Market Size by Application (2015-2020)
• 5.2 Global Novel Antiviral Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Novel Antiviral Drugs Market Size (2015-2020)
• 6.2 Novel Antiviral Drugs Key Players in North America (2019-2020)
• 6.3 North America Novel Antiviral Drugs Market Size by Type (2015-2020)
• 6.4 North America Novel Antiviral Drugs Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Novel Antiviral Drugs Market Size (2015-2020)
• 7.2 Novel Antiviral Drugs Key Players in Europe (2019-2020)
• 7.3 Europe Novel Antiviral Drugs Market Size by Type (2015-2020)
• 7.4 Europe Novel Antiviral Drugs Market Size by Application (2015-2020)

8 China

• 8.1 China Novel Antiviral Drugs Market Size (2015-2020)
• 8.2 Novel Antiviral Drugs Key Players in China (2019-2020)
• 8.3 China Novel Antiviral Drugs Market Size by Type (2015-2020)
• 8.4 China Novel Antiviral Drugs Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Novel Antiviral Drugs Market Size (2015-2020)
• 9.2 Novel Antiviral Drugs Key Players in Japan (2019-2020)
• 9.3 Japan Novel Antiviral Drugs Market Size by Type (2015-2020)
• 9.4 Japan Novel Antiviral Drugs Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Novel Antiviral Drugs Market Size (2015-2020)
• 10.2 Novel Antiviral Drugs Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Novel Antiviral Drugs Market Size by Type (2015-2020)
• 10.4 Southeast Asia Novel Antiviral Drugs Market Size by Application (2015-2020)

11 India

• 11.1 India Novel Antiviral Drugs Market Size (2015-2020)
• 11.2 Novel Antiviral Drugs Key Players in India (2019-2020)
• 11.3 India Novel Antiviral Drugs Market Size by Type (2015-2020)
• 11.4 India Novel Antiviral Drugs Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Novel Antiviral Drugs Market Size (2015-2020)
• 12.2 Novel Antiviral Drugs Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Novel Antiviral Drugs Market Size by Type (2015-2020)
• 12.4 Central & South America Novel Antiviral Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Roche Holding AG
  • 13.1.1 Roche Holding AG Company Details
  • 13.1.2 Roche Holding AG Business Overview and Its Total Revenue
  • 13.1.3 Roche Holding AG Novel Antiviral Drugs Introduction
  • 13.1.4 Roche Holding AG Revenue in Novel Antiviral Drugs Business (2015-2020))
  • 13.1.5 Roche Holding AG Recent Development
• 13.2 GlaxoSmithKline
  • 13.2.1 GlaxoSmithKline Company Details
  • 13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
  • 13.2.3 GlaxoSmithKline Novel Antiviral Drugs Introduction
  • 13.2.4 GlaxoSmithKline Revenue in Novel Antiviral Drugs Business (2015-2020)
  • 13.2.5 GlaxoSmithKline Recent Development
• 13.3 Bristol-Myers Squibb
  • 13.3.1 Bristol-Myers Squibb Company Details
  • 13.3.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  • 13.3.3 Bristol-Myers Squibb Novel Antiviral Drugs Introduction
  • 13.3.4 Bristol-Myers Squibb Revenue in Novel Antiviral Drugs Business (2015-2020)
  • 13.3.5 Bristol-Myers Squibb Recent Development
• 13.4 AbbVie
  • 13.4.1 AbbVie Company Details
  • 13.4.2 AbbVie Business Overview and Its Total Revenue
  • 13.4.3 AbbVie Novel Antiviral Drugs Introduction
  • 13.4.4 AbbVie Revenue in Novel Antiviral Drugs Business (2015-2020)
  • 13.4.5 AbbVie Recent Development
• 13.5 Johnson & Johnson
  • 13.5.1 Johnson & Johnson Company Details
  • 13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
  • 13.5.3 Johnson & Johnson Novel Antiviral Drugs Introduction
  • 13.5.4 Johnson & Johnson Revenue in Novel Antiviral Drugs Business (2015-2020)
  • 13.5.5 Johnson & Johnson Recent Development
• 13.6 Merck & Co
  • 13.6.1 Merck & Co Company Details
  • 13.6.2 Merck & Co Business Overview and Its Total Revenue
  • 13.6.3 Merck & Co Novel Antiviral Drugs Introduction
  • 13.6.4 Merck & Co Revenue in Novel Antiviral Drugs Business (2015-2020)
  • 13.6.5 Merck & Co Recent Development
• 13.7 Novartis
  • 13.7.1 Novartis Company Details
  • 13.7.2 Novartis Business Overview and Its Total Revenue
  • 13.7.3 Novartis Novel Antiviral Drugs Introduction
  • 13.7.4 Novartis Revenue in Novel Antiviral Drugs Business (2015-2020)
  • 13.7.5 Novartis Recent Development
• 13.8 Dr Reddy’s
  • 13.8.1 Dr Reddy’s Company Details
  • 13.8.2 Dr Reddy’s Business Overview and Its Total Revenue
  • 13.8.3 Dr Reddy’s Novel Antiviral Drugs Introduction
  • 13.8.4 Dr Reddy’s Revenue in Novel Antiviral Drugs Business (2015-2020)
  • 13.8.5 Dr Reddy’s Recent Development
• 13.9 Gilead Sciences
  • 13.9.1 Gilead Sciences Company Details
  • 13.9.2 Gilead Sciences Business Overview and Its Total Revenue
  • 13.9.3 Gilead Sciences Novel Antiviral Drugs Introduction
  • 13.9.4 Gilead Sciences Revenue in Novel Antiviral Drugs Business (2015-2020)
  • 13.9.5 Gilead Sciences Recent Development
• 13.10 Aurobindo Pharma
  • 13.10.1 Aurobindo Pharma Company Details
  • 13.10.2 Aurobindo Pharma Business Overview and Its Total Revenue
  • 13.10.3 Aurobindo Pharma Novel Antiviral Drugs Introduction
  • 13.10.4 Aurobindo Pharma Revenue in Novel Antiviral Drugs Business (2015-2020)
  • 13.10.5 Aurobindo Pharma Recent Development
• 13.11 Cipla
  • 10.11.1 Cipla Company Details
  • 10.11.2 Cipla Business Overview and Its Total Revenue
  • 10.11.3 Cipla Novel Antiviral Drugs Introduction
  • 10.11.4 Cipla Revenue in Novel Antiviral Drugs Business (2015-2020)
  • 10.11.5 Cipla Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer